Palliative care needs are increasing and becoming more complex
Outcome measurement plays a major role in improving the quality, efficiency and availability of palliative care. Measuring these changes and causes in a patient’s health over time can help service providers focus on learning and improving the quality of services.
A Reflection of Body Cell Mass & Indicators of Cell Membrane Function
Maltron
- Muscle Mass
- Lean Mass
- Body Cell Mass (BCM)
- Malnutrition
- Cellular Biomarker (Phase Angle)
- Body Fat
- Over Hydration (OH) (Excess Fluid)
- Fat Free Mass Hydration
- Total Body Water
- Extracellular Water
- Intracellular Water
Visual Graphic Target Indicators Managing Key Parameters
Clinicians can now assess patients quickly and safely in order to help predict disease progression and patient life expectancy, independent of traditional markers. BioScan
Regular testing can help in predicting mortality risk and providing quantitative guidance for decision making both in clinical settings and in community care. Biomarker reflects the relative contributions of fluid and cellular membranes of the human body. Lower Biomarker suggests cell death or decreased cell integrity, while higher Biomarker suggests large quantities of intact cell membranes. Falling levels in Biomarker should alert clinicians to the need of therapy or palliative care.
It’s also an indicator of a healthy metabolism, BCM or Bio-cellular mass. More and more people live with chronic disease towards the end of their life. Outcome measures help to record these changes over time against the patient’s baseline health status.
Request a copy of our Brochure
Get in touch
Maltron International Ltd
20 Sirdar Road, Rayleigh,
Essex, SS6 7XF
Tel: +44 (0)1268 778251
Fax: +44 (0)1268 745176
Email: info@maltronint.com
The new BioScan touch i8
Smart technology that understands your
language, learns from your experience and helps provide better patient outcome.
The Body Composition Monitor of tomorrow defining new standards.